Links, Tweets, etc only thread for CV-19 (1 Viewer)

[kat5s]

from SC500..

 

[kat5s]

 

[kat5s]

 

[kat5s]

National Coronavirus Response: A Road Map to Reopening

This report provides a road map for navigating through the current COVID-19 pandemic in the United States. It outlines specific directions for adapting our public-health strategy as we limit the epidemic spread of COVID-19.

www.aei.org

 

[kat5s]

 

[kat5s]

 

[kat5s]

Thread

 

[kat5s]

It's pay walled, but this is the gist of it..

German researchers plan to introduce coronavirus ‘immunity certificates’ to facilitate a proper transition into post-lockdown life, as Chancellor Angela Merkel’s handling of the crisis has led to a boost in the polls.

The antibodies will indicate that the test participants have had the virus, have healed and are thereby ready to re-enter society and the workforce. The researchers plan to test 100,000 members of the public at a time, issuing documentation to those who have overcome the virus.

The researchers will use the information to determine how to properly end the county’s lockdown, including re-opening schools and allowing mass gatherings.

Germany will issue coronavirus antibody certificates to allow quarantined to re-enter society

Researchers to test thousands for immunity as Berlin plans exit strategy for pandemic lock down

www.telegraph.co.uk

 

[kat5s]

Thread..

 

[kat5s]

from SC500

 

[kat5s]

from SC500

Can We Beat SARS-CoV-2? Lessons From Other Coronaviruses

A scientist who focuses on engineering bacteriophages for use as therapeutics shares thoughts on SARS-CoV-2.

www.contagionlive.com

 

[kat5s]

from Brees4prez

The perfect virus: two gene tweaks that turned COVID-19 into a killer

We thought we had bigger things to worry about than Chinese bat coronaviruses. It is now clear we made a massive mistake.

www.smh.com.au

 

[kat5s]

from SC500

 

[kat5s]

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020 Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing…

www.jnj.com

 

[kat5s]

Ventilators are in high demand for Covid-19 patients. How do they work?

Ventilators are in high demand for #Covid19 patients. How do they work? Watch our short explainer.

www.statnews.com